Missed opportunities to prevent mother-to-child transmission of HIV in Italy.


Journal

HIV medicine
ISSN: 1468-1293
Titre abrégé: HIV Med
Pays: England
ID NLM: 100897392

Informations de publication

Date de publication:
05 2019
Historique:
accepted: 25 01 2019
pubmed: 30 3 2019
medline: 23 5 2020
entrez: 30 3 2019
Statut: ppublish

Résumé

Vertical transmission of HIV can be effectively controlled through antenatal screening, antiretroviral treatment and the services provided during and after childbirth for mother and newborn. In Italy, the National Health Service guarantees universal access to prenatal care for all women, including women with HIV infection. Despite this, children are diagnosed with HIV infection every year. The aim of the study was to identify missed opportunities for prevention of mother-to-child transmission of HIV. The Italian Register for HIV Infection in Children, which was started in 1985 and involves 106 hospitals throughout the country, collects data on all new cases of HIV infection in children. For this analysis, we reviewed the database for the period 2005 to 2015. We found 79 HIV-1-infected children newly diagnosed after birth in Italy. Thirty-two of the mothers were Italian. During the pregnancy, only 15 of 19 women with a known HIV diagnosis were treated with antiretroviral treatment, while, of 34 women who had received an HIV diagnosis before labour began, only 23 delivered by caesarean section and 17 received intrapartum prophylaxis. In 25 mothers, HIV infection was diagnosed during pregnancy or in the peripartum period. Thirty-one newborns received antiretroviral prophylaxis and 39 received infant formula. We found an unacceptable number of missed opportunities to prevent mother-to-child transmission (MCTC). Eliminating HIV MTCT is a universal World Health Organization goal. Elucidating organization failures in Italy over the past decade should help to improve early diagnosis and to reach the zero transmission target in newborns.

Identifiants

pubmed: 30924576
doi: 10.1111/hiv.12728
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

330-336

Investigateurs

Patrizia Osimani (P)
Domenico Larovere (D)
Maurizio Ruggeri (M)
Andrea Pession (A)
Giacomo Faldella (G)
Francesca Capra (F)
Sara Pulcini (S)
Valentina Zattoni (V)
Laura Dotta (L)
Antonia Aliffi (A)
Elisa Anastasio (E)
Elisa Fiumana (E)
Paola Gervaso (P)
Carlotta Montagnani (C)
Claudio Viscoli (C)
Paola Erba (P)
GianVincenzo Zuccotti (G)
Annarita Benincaso (A)
Filippo Salvini (F)
Rita Lipreri (R)
Susanna Esposito (S)
Anna Plebani (A)
Claudia Tagliabue (C)
Francesca Giubbarelli (F)
Emanuele Nicastro (E)
Andrea Lo Vecchio (A)
Wilma Buffolano (W)
Maura Agnese (M)
Amelia Romano (A)
Saitta Marcello (S)
Carlo Giaquinto (C)
Martina Pennazzato (M)
Rita Consolini (R)
Icilio Dodi (I)
Domenico Zanaboni (D)
Paolo Palma (P)
Giuseppe Pontrelli (G)
Hyppolite Tchidjou (H)
Antonio Mazza (A)
Pier Angelo Tovo (PA)
Erika Silvestro (E)
Silvia Virano (S)
Vincenzo Portelli (V)
Antonio Pellegatta (A)

Informations de copyright

© 2019 British HIV Association.

Auteurs

A Di Biagio (A)

Infectious Diseases Unit, Department of Internal Medicine, Policlinico San Martino Hospital, Genoa, Italy.

L Taramasso (L)

Infectious Diseases Unit, Department of Health Sciences (DISSAL), University of Genoa, Policlinico San Martino Hospital, Genoa, Italy.
Infectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

G Gustinetti (G)

Infectious Diseases Unit, Department of Health Sciences (DISSAL), University of Genoa, Policlinico San Martino Hospital, Genoa, Italy.

G Burastero (G)

Infectious Diseases Unit, Department of Health Sciences (DISSAL), University of Genoa, Policlinico San Martino Hospital, Genoa, Italy.

V Giacomet (V)

Department of Pediatrics, University of Milan, L. Sacco Hospital, Milan, Italy.

D La Rovere (D)

Ospedale Pediatrico Giovanni XXIII, Bari, Italy.

O Genovese (O)

Pediatric Intensive Care Unit, A. Gemelli Hospital, Catholic University of Rome, Rome, Italy.

C Giaquinto (C)

Department of Child's and Woman's Health, University of Padova, Padova, Italy.

O Rampon (O)

Department of Child's and Woman's Health, University of Padova, Padova, Italy.

I Carloni (I)

Pediatric Unit, Department of Child and Mother Health, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy.

T K Hyppolite (TK)

Unit of Immune and Infectious Diseases, Children's Hospital Bambino Gesù, Rome, Italy.

L Palandri (L)

Unit of Immune and Infectious Diseases, Children's Hospital Bambino Gesù, Rome, Italy.

S Bernardi (S)

Unit of Immune and Infectious Diseases, Children's Hospital Bambino Gesù, Rome, Italy.

E Bruzzese (E)

Department of Translational Medical Science, Section of Pediatrics, University of Naples Federico II, Naples, Italy.

R Badolato (R)

Department of Clinical and Experimental Sciences, Institute of Molecular Medicine 'Angelo Nocivelli', University of Brescia, Brescia, Italy.

C Gabiano (C)

SC Pediatric Unit, Regina Margherita Hospital, Turin, Italy.

E Chiappini (E)

Department of Health Sciences, University of Florence, Meyer Children's Hospital, Florence, Italy.

M De Martino (M)

Department of Health Sciences, University of Florence, Meyer Children's Hospital, Florence, Italy.

L Galli (L)

Department of Health Sciences, University of Florence, Meyer Children's Hospital, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH